Mylan has a lock on the particular EpiPen design for delivering epinephrine for allergy attacks that millions of patients, parents, and school nurses have come to trust. The company's main innovation has been a bright orange cap that covers the needle, but releases automatically when a patient pushes an EpiPen against her thigh, so there's no need to stop and unscrew the cover in the midst of an allergy attack. The EpiPen has been dominant for so long it makes it hard for challengers to come in with a radically different design. It would not be very difficult to create an EpiPen product, in terms of engineering," a potential competitor said. "It's not rocket science. It's purely the patent that stops us. Mylan has patent protection that lasts through 2025.

a. Using the following Market Demand and Cost information for Mylan, use the Structure-Conduct-Performance paradigm to analyze the industry for getting epinephrine into the body. Find, Price, Quantity and Profit P=1,040-Q MR=1,040-2Q MC=40